Download Papers in Refereed Journals 1. Raz R, Akerman S, Keness Y

Papers in Refereed Journals
1. Raz R, Akerman S, Keness Y, Colodner R, Reichman N, Miron D, Flatau E. The
incidence of pneumococcal carrier state in children in Northern Israel and their
susceptibility to penicillin. Israel Journal of Medical Sciences. 1993; vol.29-5: 308310.
2. Raz R, Elhanan G, Colodner R, Reiss S, Schwartzman P, Tabenkin H, and
Leshem Y. Penicillin V twice daily vs. four times daily in the treatment of
streptococcal pharyngitis. Infectious Diseases in Clinical Practice. 1995; 1: 50-54.
3. Cohen RO, Colodner R, Ziv G, Keness Y. Isolation and antimicrobial
susceptibility of obligate anaerobic bacteria recovered from the uteri of dairy cows
with retained fetal membranes and postparturient endometritis. Journal of
Veterinary Medicine. 1996; B43, 193-199.
4. Raz R, Miron D, Colodner R, Staler Z, Samara Z, Keness Y. A 1-year trial of
nasal mupirocin in the prevention of recurrent staphylococcal nasal colonization
and skin infection. Archives of Internal Medicine. 1996; 156: 1109-1112.
5. Shalev E, Battino S, Weiner E, Colodner R, Keness Y. Ingestion of yoghurt
containing lactobacillus acidophilus compared to pasteurized yoghurt as
prophylaxis for recurrent candidal vaginitis and/or bacterial vaginosis. Archives of
Family Medicine. 1996; 5: 593:596.
6. Sakran W, Raz R, Colodner R, Keness Y. Isolated susceptibility of
Streptococcus pyogenes to three macrolides. Harefuah. 1997; 9: 365-366.
7. Raz R, Soboh S, Abu Much Z, Keness Y, Rafael C, Colodner R. Pneumococcal
carriage in geriatric institute residents. Infectious Diseases in Clinical
Practice 1999; 8: 291-293.
8. Sakran W, Raz R, Levi Y, Colodner R, Koren A. Campylobacter bacteremia and
pneumonia in splenectomized patients. European Journal of Clinical Microbiology
and Infectious Diseases. 1999 Jul;18(7):496-8.
9. Bisharat N, Agmon V, Finkelstein R, Raz R, Ben-Dror G, Lerner L, Soboh S,
Colodner R, Cameron D, Wykstra D, Swerdlow D, Farmer JJ. Clinical,
epidemiological and microbiological features of a Vibrio vulnificus biogroup 3
causing outbreaks of wound infection and bacteraemia in Israel. Lancet. 1999
Oct 23;354(9188):1421-4.
10. Miron D, Colodner R, Keness Y. Age-related seroprevalence of Cryptosporidium
in Northern Israel. Israel Medical Association Journal 2000;2:343:345.
11. Colodner R, Chazan B, Kopelowitz J, Keness Y, Raz R. An anusual portal of
entry of Vibrio vulnificus – evidence of its prolonged survival on the skin. Clinical
Infectious Diseases. 2002 Mar 1;34(5):714-5
12. Colodner R, Keness Y. Evaluation of Dipstreak containing CNA-MacConkey
agar, a new bedside urine culture device. Israel Medical Association Journal
2000 Jul;2(7):563-5.
13. Rakover Y, Smuskovitz A, Colodner R, Keness Y, Rosen G. Duration of the
antibacterial effectiveness of gentamicin ear drops in external otitis. Journal of
Laryngology and Otology, November 2000, 114:827-829.
14. Colodner R, Keness Y, Bisharat N, Raz R. Misidentification of the new Vibrio
vulnificus biotype 3 by two commercial methods. Clinical Microbiology and
Infection May 2000; (6) Suppl.1:167.
15. Foxman B, Somsel P, Tallman P, Gillespie B, Raz R, Colodner R, Kandula D,
Sobel JD. Urinary tract infection among women aged 40 to 65. Behavioral and
sexual risk factors. Journal of Clinical Epidemiology 2001 Jul;54(7):710-8.
16. Colodner R, Keness Y, Chazan B, Raz R. Antimicrobial susceptibility of
community-acquired uropathogens in Northern Israel. International Journal of
Antimicrobial Agents, 2001; 18 (2):189-192.
17. Colodner R, Keness Y, Miron D, Sakran W, Chazan B, Raz R. Antimicrobial
resistance pattern of clinically significant Streptococcus pneumoniae isolates in
Northern Israel. The 11th European Congress of Clinical Microbiology and
Infectious Diseases (ECCMID) – Istanbul, Turkey. April 2001. Clinical
Microbiology and Infection 2001; (7) Suppl.1:176.
18. Colodner R, Mines M, Keness Y, Raz R. Procalcitonin and C-reactive protein
serum levels in patients with sepsis and bacteremia: a pilot study. The 11th
European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) –
Istanbul, Turkey. April 2001. Clinical Microbiology and Infection 2001; (7)
Suppl.1:182.
19. Colodner R, Salim R, Keness Y, Ben-Shlomo I. A proposed method for the
assessment of bacterial colonization of the uterine cervix during assisted
reproduction technique procedures. The 11th European Congress of Clinical
Microbiology and Infectious Diseases (ECCMID) – Istanbul, Turkey. April 2001.
Clinical Microbiology and Infection 2001; (7) Suppl.1:304.
20. Chazan B, Colodner R, Raz R. Clinical predictors of streptococcal pharyngitis in
adults. The 11th European Congress of Clinical Microbiology and Infectious
Diseases (ECCMID) – Istanbul, Turkey. April 2001. Clinical Microbiology and
Infection 2001; (7) Suppl.1:290.
21. Salim R, Ben-Shlomo I, Colodner R, Keness Y, Shalev E. Bacterial colonization
of the uterine cervix and success rate in assisted reproduction: results of a
prospective survey. Human Reproduction. 2002 Feb;17(2):337-40.
22. Marrs CF, Zhang L, Tallman P, Manning S, Somsel P, Raz R, Colodner R,
Jantunen ME, Siitonen A, Saxen H, Foxman B. Variations in ten putative
uropathogen virulence genes among urinary, fecal and periurethral Escherichia
coli. Journal of Medical Microbiology. 2002 Feb;51(2):138-42.
23. Colodner R, Reznik B, Aulov V, Gal V, Yenifiliz R, Levy P, Keness Y.
Comparison of two bedside urine culture devices containing chromogenic agar.
The 12th European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID) – Milano, Italy. April 2002. Clinical Microbiology and Infection 2002; (8)
Suppl.1:225.
24. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, Lavi I,
Stamm W. Empiric Use of Trimethoprim-Sulfamethoxazole (TMP-SMX) in the
Treatment of Women with Uncomplicated Urinary Tract Infections, in a
Geographical Area with a High Prevalence of TMP-SMX-Resistant
Uropathogens. Clinical Infectious Diseases 2002 May 1;34(9):1165-9.
25. Genizi J, Miron D, Colodner R, Lumilsky D, Bykov S, Horowitz Y. Salmonella
sacroiliitis and bacteremia in a child. Harefuah. 2002 Aug;141(8):685-8.
26. Smolkin V, Koren A, Raz R, Colodner R, Sakran W, Halevy R. Procalcitonin as a
marker of acute pyelonephritis in infants and children. Pediatric Nephrology 2002;
17(6): 409-412.
27. Sakran W, Miron D, Halevy R, Colodner R, Smolkin V, Koren A. Community
acquired urinary tract infection among hospitalized children in northern Israel:
pathogens, susceptibility patterns and urinary tract anomalies. Harefuah 2003
Apr;142(4):249-52.
28. Raz R, Colodner R, Rohana Y, Battino S, Rottensterich E, Wasser I, Stamm W.
Effectiveness of estriol containing vaginal pessaries and nitrofurantoin
macrocrystal therapy in the prevention of recurrent urinary tract infection in
postmenopausal women. Clinical Infectious Diseases. 2003 Jun 1;36(11):1362-8.
29. Colodner R, Sakran W, Miron D, Teitler N, Khavalevsky E, Kopelowitz J. Listeria
monocytogenes cross-contamination in a nursery. In press. American Journal of
Infection Control 2003;31(5):322-4.
30. Miron D, Lev A, Colodner R, Merzel Y. Compartment syndrome of the calf as the
initial manifestation of Vibrio Vulnificus associated severe infection in a child with
congenital spherocytosis. The Pediatric Infectious Disease Journal 2003;
22(7):666-8.
31. Saliba WR, Goldstein LH, Raz R, Mader R, Colodner R, Elias MS. Subacute
necrotizing fasciitis caused by gas-producing Staphylococcus aureus. European
Journal of Clinical Microbiology and Infectious Diseases. 2003 Oct; 22(10): 6124.
32. Mendelson G, Yearmack Y, Granot E, Ben-Israel J, Colodner R, Raz R.
Staphylococcus aureus carrier state among elderly residents in a long-term care
facility. Journal of the American Medical Directors Association 2003;4(3):125-7.
33. Chazan B, Shaabi M, Bishara E, Colodner R, Raz R. Clinical predictors of
streptococcal pharingitis in adults. The Israel Medical Association Journal. June
2003;5:413-5.
34. Raz R, Sakran W, Chazan B, Colodner R, Kunin C. Long-term follow-up of
women hospitalized for acute pyelonephritis. Clinical Infectious Diseases. 2003
Oct 15;37(8):1014-20.
35. Colodner R, Edelstein H, Chazan B, Raz R. Vaginal colonization by oral
administered Lactobacillus rhamnosus-GG (LGG). The Israel Medical Association
Journal. Nov 2003;5:767-9.
36. Colodner R, Raz R, Meir I, Lazarovich Z, Lerner L, Kopelowitz J, Keness Y,
Sakran W, Ken-Dror S, Bisharat N. Identification of the new emerging pathogen
Vibrio vulnificus biotype 3 using commercially-available phenotypic methods.
Journal of Clinical Microbiology. 2004;42(9):4137-4140.
37. Sakran W, Valinsky L, Koren A, Bor N, Yishay R, Colodner R. Early onset of
neonatal Streptococcus pneumoniae bacteremia and septic arthritis. Clinical
Pediatrics. 2004;43(6)579-81.
38. Colodner R, Rock W, Chazan B, Keller N, Guy N, Raz R. Risk factors for the
development of extended-spectrum beta-lactamases in non-hospitalized patients.
European Journal of Clinical Microbiology and Infectious Diseases. March
2004;23(3):163-7.
39. Sakran W, Raz R, Chazan B, Koren A, Yishai R, Colodner R. Susceptibility of
Streptococcus pyogenes to two macrolides in Northern Israel. International
Journal of Antimicrobial Agents. 2004; 23(5):517-519.
40. Sakran W, Mazzawi S, Merzel Y, Colodner R. Streptococcal necrotizing fasciitis
with toxic shock syndrome following cervical adenitis. International Journal of
Pediatric Otorhinolaringology. Int J Pediatr Otorhinolaryngol. 2004
Sep;68(9):1209-13.
41. Colodner R, Raz R, Chazan B, Sakran W. Susceptibility pattern of ESBLproducing bacteria isolated from inpatients to five antimicrobial drugs in a
community hospital in northern Israel. International Journal of Antimicrobial
Agents. 2004; 24(4):409-410
42. Miron D, Torem M, Merom R, Colodner R. Azithromycin as an Alternative to
Nalidixic Acid for Therapy of Childhood Shigellosis. The Pediatric Infectious
Disease Journal. 2004 Apr; 23(4):367-8
43. Chazan B, Colodner R, Polacheck Y, Shoufani A, Rozenman D, Raz R.
Cutaneous infection by Cylindrocarpon lichenicola in an immunocompetent
patient. Journal of Travel Medicine. 2004 Sep-Oct;11(5):331-2.
44. Chazan B, Raz R, Sakran W, Colodner R. Improved antimicrobial susceptibility
of community-acquired uropathogens in northern Israel (1995-1999-2002). Int J
Antimicrob Agents. 2004 Jul;24(1):89-92.
45. Johnson JR, Kuskowski MA, O’Bryan TT, Colodner R, Raz R. Virulence
genotype and phylogenetic origin in relation to antibiotic resistance profile among
Escherichia coli isolates from Israeli women with acute uncomplicated cystitis.
Antimicrobial Agents and Chemotherapy. 2005 Jan;49(1):26-31.
46. Johnson JR, Murray AC, Kuskowski MA, Schubert S, Prere MF, Picard B,
Colodner R, Raz R and the Trans-Global Initiative for Antimicrobial Resistance
Analysis (TIARA) Investigators. Global Distribution and Characteristics of
Escherichia coli Clonal Group A. Emerging Infectious Diseases. 2005
Jan;11(1):141-5.
47. Colodner R, Raz R. Extended-spectrum beta-lactamases: the end of
cephalosporins? Israel Medical Association Journal. 2005; 7:336-338
48. Chen Y, Colodner R, Chazan B, Raz R. Pharyngotonsillitis due to
Arcanobacterium haemolyticum in Northern Israel. Israel Medical Association
Journal. 2005 Apr;7:236-237.
49. Sakran W, Makary H, Colodner R, Ashkenazi D, Rakover Y, Halevy R, Koren A.
Acute otitis media in infants less than three months of age: clinical presentation,
etiology and concomitant diseases. International Journal of Pediatric
Otorhinolaringology. 2006;70:613-617.
50. Colodner R. Extended-spectrum beta-lactamases: a challenge for clinical
microbiologists and infection control specialists. American Journal of Infection
Control. 2005;33(2):104-107.
51. Raz R, Colodner R, Kunin CM. Who are you – Staphylococcus saprophyticus?
Clinical Infectious Diseases. 2005. 40(6):896-8.
52. Johnson JR, Johnston B, Kuskowski MA, Colodner R, Raz R. Spontaneous
conversion to quinolone and fluoroquinolone resistance among wild-type
Escherichia coli isolates in relation to phylogenetic background and virulence
genotype. Antimicrobial Agents and Chemotherapy. 2005; 49:4739-44.
53. Miron D, Horowitz Y, Lumelsky D, Hanania S, Colodner R. Dual pulmonary
infection with Candida dubliniensis and Aspergillus fumigatus in a child with
chronic granulomatous disease. Journal of Infection. 2005;50(1):72-5.
54. Raz R, Ben-Israel Y, Gronich D, Granot E, Colodner R, Visotzky I. Usefulness of
blood cultures in the management of febrile patients in long-term care facilities.
European Journal of Clinical Microbiology and Infectious Diseases. 2005
Nov;24(11):745-8.
55. Colodner R, Reznik B, Gal V, Yamazaki H, Hanaki H, Kubo R. Evaluation of a
novel kit – Cica-Beta Test I – for the rapid detection of extended-spectrum betalactamases. European Journal of Clinical Microbiology and Infectious Diseases.
2006;25(1):49-51.
56. Chen Y, Nitzan O, Saliba W, Chazan B, Colodner R, Raz R. Are blood cultures
necessary in the management of women with complicated pyelonephritis?
Journal of Infection. 2006;53(4):235-40.
57. Colodner R, Eliasberg T, Chazan B, Raz R. Clinical significance of bacteriuria
with low colony count of Enterococcus spp. European Journal of Clinical
Microbiology and Infectious Diseases. (2006) 25:238-241.
58. Turgeman Y, Levahar P, Lavi I, Shneor A, Colodner R, Samra Z, Bloch L,
Rosenfeld T. Adult calcific aortic stenosis and Chlamydia pneumoniae: the role of
Chlamydia infection in valvular calcification. The Israel Medical Association
Journal. 2006 Jul;8(7):464-8.
59. Colodner R, Ken-Dror S, Kavenshtock B, Chazan B, Raz R. Epidemiology and
clinical characteristics of patients with Staphylococcus saprophyticus bacteriuria
in Israel. Infection. 2006 Oct;34(5):278-281.
60. Nachum Z, Colodner R, Salim R, Gabarin D, Batino S, Shalev E. Probiotic
yogurt for the prevention of bacterial vaginosis recurrence in pregnant women at
risk of preterm labor. American Journal of Obstetrics and Gynecology.
2006;193(6): S192.
61. Colodner R, Samra Z, Keller N, Sprecher H, Block C, Peled N, Lazarovitch T,
Bardenstein R, Schwartz-Harari O, Carmeli Y. First national surveillance of
susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli
and Klebsiella spp to antimicrobials in Israel. Diagnostic Microbiology and
Infectious Diseases. 2007;57(2):201-205.
62. Chazan B, Kopelman D, Katz Z, Kniznik D, Chen Y, Colodner R, Raz R.
Fournier’s gangrene (FG) as the initial presentation of HIV infection. International
Journal of Infectious Diseases. 2007 Mar;11(2):184-185.
63. Rock W, Colodner R, Chazan B, Elias M, Raz R. Ten years surveillance of
antimicrobial susceptibility of community-acquired Escherichia coli and other
uropathogens in northern Israel (1995-2005). Israel Medical Association Journal.
2007:9:803-805.
64. Colodner R, Kometiani I, Chazan B, Raz R. Risk factors for community-acquired
urinary tract infection due to quinolone-resistant Escherichia coli. Infection. 2008;
36:41-45.
65. Chazan B, Raz R, Shental Y, Sprecher H, Colodner R. Bacteremia and
pyelonephritis caused by Lactobacillus jensenii in a patient with urolithiasis: a
case report. Israel Medical Association Journal. 2008 Feb;10(2):164-5.
66. Davidovich T, Rimbroth S, Hazan B, Colodner R, Markel A. Recurrent
septicemia and osteomyelitis caused by Pasteurella multocida in a patient with
chronic lymphativ leukemia. Israel Medical Association Journal. 2008 (10):653654.
67. Colodner R, Nuri Y, Chazan B, Raz R. Community-acquired and hospitalacquired candiduria: comparison of prevalence and clinical characteristics.
European Journal of Clinical Microbiology and Infectious Diseases. 2008;
27(4):301-305.
68. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella zoster virus in health
care workers in northern Israel: seroprevalence and predictive value of history of
varicella infection. Am J Infect Control. 2008 Aug;36(6):436-8.
69. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella Zoster Virus in
Health Care Workers in Northern Israel: Seroprevalence and Predictive Value of
History of Varicella Infection. Accepted for publication at: American Journal of
Infection Control, 2008;36(6):436-8.
70. Chazan B, Colodner R, Teitler N, Chen Y, Raz R. Varicella Zoster Virus in
Health Care Workers in Northern Israel: Seroprevalence and Predictive Value of
History of Varicella Infection. Accepted for publication at: American Journal of
Infection Control, 2008;36(6):436-8.
71. Galayduyk N, Colodner R, Chazan B, Flatau E, Lavi I, Raz R. Adherence to
guidelines on empiric use of antibiotics in the emergency room. Infection. 2008;
36(5):408-14.
72. Leavitt A, Chmelnitsky I, Colodner R, Ofek I, Carmeli Y, Navon-Venezia S.
Ertapenem resistance among extended spectrum beta-lactamases producing
Klebsiella pneumoniae. Journal of Clinical Microbiology. 2009;47(4): p.969-974.
73. Chazan B, Raz R, Teitler N, Nitzan O, Edelstein H, Colodner R. Epidemiology
and susceptibility to antimicrobials in community, hospital and long-term-carefacility bacteremia in Northern Israel – a 6-Years Surveillance. Israel Medical
Association Journal. 2009;11:592-597.
74. Colodner R, Nitzan O, Chazan B, Edelstein H, Raz R. Mannose-binding lectin in
pre-menopausal women with recurrent urinary tract infections. Clinical
Microbiology and Infection. 2010 Sep;16(9):1394-8
75. Nitzan O, Suponitzky U, Kennes Y, Chazan B, Raz R, Colodner R. Is
chloramphenicol making a comeback? Israel Medical Association Journal 2010:
12: June: 371-374.
76. Shibli F, Chazan B, Nitzan O, Flatau I, Edelstein H, Blondheim O, Raz R,
Colodner R. Etiology of community-acquired pneumonia in hospitalized
patients in northern Israel. The Israel Medical Association Journal. 2010;
12:477-482.
77. Chazan B, Colodner R, Edelstein H, Raz R. Seasonal variation in E. coli
bloodstream infections in Northern Israel. Clinical Microbiology and Infection.
Epub ahead of print July 2010.
78. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM,
Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V,
Mittermayer H, Goossens M, Tihic N, Proevska Y, Tambic A, PieridouBagatzouni D, Zemlickova H, Hrabak J, Hammerum AM, Ivanova M, Jalavi J,
Toth A, Hardarson H, Boo TW, Colodner R, Monaco M, Garcia Fernandez A,
Rossolini G, Balode A, Miciuleviciene J, Caruana P, Skov G, Samuelsen O,
Hryniewicz W, Gniadkowski M, Caniça M, Manageiro V, Codita I, Mueller-Premru
M, Kolman J, Iglesias JO, Edquist PJ, Droz S, Leverstein M, Huijsdens X.
Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a
meeting of national experts. European Surveillance. 2010 Nov 18;15(46). pii:
19711.
79. Sakran W, Levin C, Keness Y, Colodner R, Koren A. Clinical spectrum of
serious bacterial infections among splenectomized patients with
hemoglobinopathies in Israel: a 37 years follow up study. Infection. 2011 Aug 25.
[Epub ahead of print].
80. Dodiuk-Gad R, Cohen-Barak E, Ziv M, Shani-Adir A, Shalev S, Chazan B, Raz R,
Colodner R, Amichai B, Zlotogorski A, Keness Y, Rozenman D.Bacteriological
aspects of Darier's disease. J Eur Acad Dermatol Venereol. 2013
Nov;27(11):1405-9.
81. Amna MA, Chazan B, Raz R, Edelstein H, Colodner R. Risk factors for nonEscherichia coli community-acquired bacteriruria. Infection. Infection. 2013
Apr;41(2):473-7.
82. Nitzan O, Keness Y, Colodner R, Saliba W, Edelstein H, Raz R, Chazan B.
Chloramphenicol use and susceptibility patterns in Israel: a national survey. Israel
Medical Association Journal. 2015;17:27-31.
83. Chazan B, Raz R, Edelstein H, Keness Y, Gal V, Colodner R. Susceptibility of
Group A Streptococcus to antimicrobial agents in Northern Israel – A surveillance
study. Microbial Drug Resistance. Accepted April 2015. In Press.